Overview
My area of clinical research is drug development focused on novel antithrombotic medications, with the express purpose of obtaining worldwide regulatory approval. My goal is to bring new pharmaceutical treatments for patients with venous and arterial thromboembolic disease to healthcare providers.
Key Words
anticoagulants antiplatelet medications antithrombotic drugs arterial thrombosis bleeding diatheses hemostasis hypercoagulable states prophylaxis thrombocytopenia thrombosis thromboembolic disease treatment venous thrombosis
von Willebrand disease
Key Words
anticoagulants antiplatelet medications antithrombotic drugs arterial thrombosis bleeding diatheses hemostasis hypercoagulable states prophylaxis thrombocytopenia thrombosis thromboembolic disease treatment venous thrombosis
von Willebrand disease
Current Appointments & Affiliations
Adjunct Associate Professor in the Department of Medicine
·
2000 - Present
Medicine, Hematology,
Medicine
Education, Training & Certifications
Thomas Jefferson University ·
1979
M.D.